BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/13/2014 7:02:00 PM | Browse: 1366 | Download: 2052
 |
Received |
|
2014-07-04 08:46 |
|
Peer-Review Started |
|
2014-07-04 13:48 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-07-18 15:29 |
|
Revised |
|
2014-07-19 02:55 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-08-29 19:09 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-08-29 19:20 |
|
Articles in Press |
|
2014-08-29 19:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-10-14 16:27 |
|
Publish the Manuscript Online |
|
2014-12-13 19:01 |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nasser Mikhail |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nasser Mikhail, MD, MSc, Department of Medicine, Endocrine Division, OliveView-UCLA Medical Center, 14445 Olive View Dr, Sylmar, CA 91342,
United States. nmikhail@dhs.lacounty.gov
|
| Key Words |
Type 2 diabetes; Canagliflozin dapagliflozin; Weight loss; Hypoglycemia; Chronic kidney disease; Genital infection |
| Core Tip |
Sodium-glucose co-transporter type 2 inhibitors are recently approved drugs for type 2 diabetes with unique mechanism of action. In this minireview, the author provides a practical approach on how to select the best candidates for these drugs.
|
| Publish Date |
2014-12-13 19:01 |
| Citation |
Mikhail N. Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes. World J Diabetes 2014; 5(6): 854-859 |
| URL |
http://www.wjgnet.com/1948-9358/full/v5/i6/854.htm |
| DOI |
http://dx.doi.org/10.4239/wjd.v5.i6.854 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
